Author
Listed:
- Cate Bailey
(The University of Melbourne)
- Kim Dalziel
(The University of Melbourne)
- Renee Jones
(The University of Melbourne)
- Harriet Hiscock
(Murdoch Children’s Research Institute
Royal Children’s Hospital
University of Melbourne)
- Nancy J. Devlin
(The University of Melbourne)
- Tessa Peasgood
(The University of Melbourne)
Abstract
Background The EuroQol Health and Wellbeing Short Version (EQ-HWB-S) instrument has been developed to measure the health and wellbeing of care-recipients and their caregivers for use in economic evaluation.The EQ-HWB-S has nine items, and pilot UK preference weights have now been developed. Objective We aimed to investigate the validity of the instrument in parents of children with and without health conditions. Methods EQ-HWB-S data were sourced from an Australian paediatric multi-instrument comparison study. We analysed the baseline characteristics and response distribution of the EQ-HWB-S items. Assessment of known-group validity was conducted for EQ-HWB-S items, level sum-scores and preference-weighted scores, including partial effects. Known-group analyses included three child health variables and where caregivers reported coronavirus disease 2019 (COVID-19) had impacted their wellbeing. We included analyses across gender, controlled for child and parent demographic variables, and compared scores across child health conditions. Results Item responses were distributed as expected, with higher skew for mobility and activities. Parents experienced high levels of exhaustion. We detected significant differences between groups for level sum-scores and preference-weighted scores, as hypothesised; all tests were significant (p
Suggested Citation
Cate Bailey & Kim Dalziel & Renee Jones & Harriet Hiscock & Nancy J. Devlin & Tessa Peasgood, 2024.
"The Validity of the EuroQol Health and Wellbeing Short Version (EQ-HWB-S) Instrument in Parents of Children With and Without Health Conditions,"
PharmacoEconomics, Springer, vol. 42(1), pages 163-179, June.
Handle:
RePEc:spr:pharme:v:42:y:2024:i:1:d:10.1007_s40273-024-01351-5
DOI: 10.1007/s40273-024-01351-5
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:pharme:v:42:y:2024:i:1:d:10.1007_s40273-024-01351-5. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.